You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
麗年國際(09918.HK)向一間美國定點照護分子診斷公司交付若干用於2019冠狀病毒快速測試測試儀對接儀器
格隆匯 06-03 20:29

格隆匯6月3日丨麗年國際(09918.HK)公吿,集團已成功於2021年4月及5月向一間位於美國的定點照護分子診斷公司交付若干用於2019冠狀病毒快速測試的測試儀對接儀器。集團向該客户提供一站式合約製造服務,製造及供應測試儀對接儀器。對接儀器由印刷電路板組件、傳感器、電源線、電子元件及塑膠件組成,為一個用於插入一次性測試盒的平台。

對接儀器提供加熱功能,在測試盒產生生物化學反應後,顯示診斷測試結果。根據迄今為止從上述分子診斷公司收到的確認採購訂單,對接儀器的確認採購訂單總價值約為7.8百萬美元。集團預計,鑑於疫情的發展,於可預見未來,該新產品將有持續需求。

此外,集團以SapiVents商標開發一種無創且成相對較低的緊急呼吸機。緊急呼吸機能夠為2019冠狀病毒患者提供呼吸輔助。集團正就在急需醫療設備幫助患者抗擊疾病的國家推出及分銷緊急呼吸機積極開展初步評估。巴西是受疫情衝擊最嚴重的國家一。集團計劃透過行業顧問向巴西相關政府部門申請監管批准,以在巴西推出及分銷我們的緊急呼吸機。集團明白申請及審批程序包括但不限於樣品測試、工廠審核及認證。公司於現階段無法建議其擬在巴西分銷緊急呼吸機是否最終及何時會取得所有相關批准,亦無法建議即使獲得相關監管批准,公司是否能獲取任何客户的採購訂單。

鑑於2019冠狀病毒流行病的持續爆發及其在全球範圍內的蔓延,集團預計,對能夠滿足疫情防控需要的產品將有持續的需求。董事會對集團能夠為抗擊疫情作出貢獻感到欣慰,並認為新產品代表集團在開發及探索新產品應用及類別的努力,以及將產品供應擴展至醫療產品的機會。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account